Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT00171860
Eligibility Criteria:
Inclusion Criteria:
Idiopathic hypereosinophilic syndromes are included provided they belong to one of the following categories:
1. previously treated and showing documented resistance or refractoriness to, or intolerance of, prednisone, hydroxyurea or interferon-alpha.
2. not previously treated but with documented Fip1L1-PDGFRA fusion protein
Exclusion Criteria:
* Other diseases associated with hypereosinophilia
* Serum creatinine, serum bilirubin, AST, ALT more than twice the upper normal limit.
* ECOG performance status \>3
Other protocol-defined exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00171860
Study Brief:
Protocol Section:
NCT00171860